Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer

BACKGROUND: The role of adjuvant chemotherapy (ACT) for patients with stage IB–IIA non‐small cell lung cancer (NSCLC) according to the eighth edition of the AJCC TNM staging system remains controversial. METHODS: Data were collected from patients with NSCLC stage IB–IIA according to the eighth editi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Pei, Duan, Jianchun, Bai, Hua, Wang, Zhijie, Gao, Shugeng, Tan, Fengwei, Gao, Yushun, Wang, Xin, Wan, Rui, Xu, Jiachen, He, Xiran, Feng, Xiaoshuang, Yu, Ruofei, Sun, Jing, Zhao, Zhe, Fei, Kailun, Li, Ni, He, Jie, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779205/
https://www.ncbi.nlm.nih.gov/pubmed/33111432
http://dx.doi.org/10.1111/1759-7714.13685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779205/
https://www.ncbi.nlm.nih.gov/pubmed/33111432
http://dx.doi.org/10.1111/1759-7714.13685

Ejemplares similares